Osaic Holdings’s Perspective Therapeutics CATX Stock Holding History

Osaic Holdings’s Portfolio CATX Stock Details CATX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.13K	Buy	1,503 +1,003	+201%	+$3.79K	﹤0.01%	6927
2026 Q1	$2.08K	Sell	500 -1,000	-67%	-$4.22K	﹤0.01%	7028
2025 Q4	$4.13K	Sell	1,500 -79	-5%	-$225	﹤0.01%	6808
2025 Q3	$5.29K	Buy	1,579 +534	+51%	+$1.95K	﹤0.01%	6713
2025 Q2	$3.59K	Hold	1,045	–	–	﹤0.01%	6720
2025 Q1	$2.23K	Buy	1,045 +1,000	+2,222%	+$3K	﹤0.01%	6550
2024 Q4	$143	Hold	45	–	–	﹤0.01%	7210
2024 Q3	$600	Buy	+45	New	+$598	﹤0.01%	6973
2023 Q3	–	Sell	-10	Closed	-$63	–	7406
2023 Q2	$63	Buy	+10	New	+$61	﹤0.01%	7320
2022 Q1	–	Sell	-150	Closed	-$1K	–	7255
2021 Q4	$1K	Hold	150	–	–	﹤0.01%	7146
2021 Q3	$1K	Hold	150	–	–	﹤0.01%	6981
2021 Q2	$1K	Hold	150	–	–	﹤0.01%	6825
2021 Q1	$2K	Hold	150	–	–	﹤0.01%	6467
2020 Q4	$1K	Hold	150	–	–	﹤0.01%	6182
2020 Q3	$1K	Hold	150	–	–	﹤0.01%	5977
2020 Q2	$1K	Hold	150	–	–	﹤0.01%	5905
2020 Q1	$1K	Buy	+150	New	+$1.13K	﹤0.01%	5805

Other funds holding CATX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

SSC

Spruce Street Capital New York $510M AUM

Osaic Holdings's CATX Position: Q2 2026 in Review

Osaic Holdings increased its Perspective Therapeutics (CATX) stake by 201% in Q2 2026, buying an estimated $3.79K and bringing the position to 1,503 shares worth $5.13K. The position accounts for ﹤0.01% of the portfolio, ranked #6927.

Osaic Holdings first reported a position in CATX in Q1 2020 and has held it in 17 quarters since. The position peaked at $5.29K in Q3 2025. 131 funds tracked by Wall St. Rank hold CATX as of Q2 2026.

Osaic Holdings held 1,503 shares of Perspective Therapeutics worth $5.13K as of Q2 2026.
Osaic Holdings bought 1,003 Perspective Therapeutics shares in Q2 2026, an estimated $3.79K.
Perspective Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #6927 holding.
Osaic Holdings first reported a position in Perspective Therapeutics in Q1 2020 and has held it in 17 quarters since.
Osaic Holdings's Perspective Therapeutics position peaked at $5.29K in Q3 2025.
131 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.